Cancer Research

Published by: American Association for Cancer Research  

People

  1. Drilon
    Drilon
  2. Ladanyi
    Ladanyi
  3. Schram
    Schram
  4. Berger
    Berger
  5. Arcila
    Arcila
  6. De Stanchina
    De Stanchina
  7. Rosen
    Rosen
  8. Chang
    Chang
  9. Kulick
    Kulick
  10. Mattar
    Mattar

Groups

  1. Department of Medicine (23)
  2. Solid Tumor Oncology Division (23)
  3. Thoracic Oncology (23)
  4. Department of Pathology and Laboratory Medicine (12)
  5. Early Drug Development Service (10)
  6. GSK Faculty (9)
  7. Human Oncology and Pathogenesis Program (9)
  8. Weinberg Fellows (8)
  9. Sloan Kettering Institute Postdocs (7)
  10. Tow Center for Developmental Oncology (TCDO) (7)
Search Within
  1. "Alexander Drilon"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (1)
Groups
  1. Department of Medicine (23)
  2. Solid Tumor Oncology Division (23)
  3. Thoracic Oncology (23)
  4. Department of Pathology and Laboratory Medicine (12)
  5. Early Drug Development Service (10)
  6. GSK Faculty (9)

More Groups

People
  1. Alexander Drilon (23)
  2. David Hyman (8)
  3. Marc Ladanyi (7)
  4. Alison Schram (5)
  5. Jaclyn Hechtman (5)
  6. Maurizio Scaltriti (4)

More People

Years
  1. 2022 (5)
  2. 2021 (5)
  3. 2020 (3)
  4. 2019 (8)
  5. 2018 (1)
  6. 2015 (1)
Publishers
  1. American Association for Cancer Research (23)

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Variability in NTRK gene fusions does not appear to impact response to larotrectinib
    Meeting Abstract

    Ladanyi, M.; Roy-Chowdhuri, S.; Ritterhouse, L.; Sahm, F.; Norenberg, R.; Shen, K.; Chen, C.; Fellous, M.; Brega, N.; van Tilburg, C. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • The preclinical selectivity and activity of APS03118, a highly selective and potent next-generation RET inhibitor
    Meeting Abstract

    Drilon, A.; Zhong, J.; Lu, Y.; Liu, Y.; Wang, H.; Chen, M.; Chen, X.; Zhu, J.; Lu, S.; Subbiah, V.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Switching inhibitor class overcomes crizotinib resistance in a MET fusion-positive NSCLC with a novel acquired MET G1090A mutation
    Meeting Abstract

    Murciano-Goroff, Y. R.; Kannan, S.; Chang, J. C.; Benayed, R.; Blokhin, I.; Rekhtman, N.; Sisk, A. E.; Gibson, J.; Judka, L.; Kaplanis, L.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Splicing factor mutant lung cancers: A comprehensive molecular and clinicopathologic characterization
    Meeting Abstract

    Harada, G.; Falcon, C. J.; Santini, F. C.; Chang, J. C.; Yang, S. R.; Arcila, M. E.; Rekhtman, N.; Drilon, A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • OncoKB, MSK's precision oncology knowledge base
    Meeting Abstract

    Suehnholz, S. P.; Nissan, M.; Zhang, H.; Kundra, R.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Carrero, S.; Arcila, M. E.; Ladanyi, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Efficacy and safety of selpercatinib in RET fusion-positive cancers other than lung or thyroid cancers
    Meeting Abstract

    Subbiah, V.; Konda, B.; Bauer, T.; McCoach, C.; Falchook, G.; Takeda, M.; Patel, J.; Weiss, J.; Peled, N.; Bazhenova, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with TRK fusion cancer treated with larotrectinib
    Meeting Abstract

    Drilon, A.; Kummar, S.; Albert, C. M.; Nagasubramanian, R.; Hechtman, J. F.; Reeves, J. A.; Beckmann, G.; Rudolph, M.; Wierzbińska, J. A.; Dima, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Molecular characteristics of repotrectinib that enable potent inhibition of TRK fusion proteins and broad mutant selectivity
    Meeting Abstract

    Drilon, A.; Zhai, D.; Rogers, E.; Deng, W.; Chen, X.; Sprengeler, P.; Reich, S. H.; Murray, B. W.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • MYC promotes tyrosine kinase inhibitor resistance in ROS1 fusion positive lung cancers
    Meeting Abstract

    Iyer, S. R.; Odintsov, I.; Schoenfeld, A. J.; Sato, H.; Siau, E.; Drilon, A.; Riely, G. J.; Somwar, R.; Ladanyi, M.; Davare, M. A.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of larotrectinib in patients with TRK fusion breast cancer
    Meeting Abstract

    Rosen, E. Y.; Italiano, A.; Juric, D.; Reeves, J. A.; Dima, L.; Brega, N.; Drilon, A.
    Cancer Research (2021)

    Fulltext@MSK | Save

    • Cancer Research – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association Tor Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 Unknown
    Cancer research 15387445 The Authors the American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer research 15387445 American Association for Cancer Research
    Cancer Research 00085472 Unknown
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer research 15387445 Unknown
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer
    Cancer Research 00085472 The Authors
    Cancer Research 00085472 The Authors the American Association for Cancer Research